MIPS

Fake News – MIPS Style

By Jim Tate – I sure hear a lot about fake news these days. In the world of politics, we hear a constant chant: “This is fake, that is fake, everything is fake”. I guess it is in the eye of the beholder as to what is true. There is the whole truth, the partial truth, misstatements of fact and downright Pinocchio lies.

Read More

MIPS 2017: Time Runneth Out

By Jim Tate – There is less than two weeks left on the clock. October 2nd is coming fast and brings the beginning of the last 90-day MIPS performance period for 2017. If plans have not already been made then this week is the last opportunity.


Understanding Group and Individual Reporting for MIPS

By Matthew Fusan – There are less than four months remaining in the first MIPS performance year and having a plan to monitor and drive improvement in targeted areas is critical to maximize your score and reimbursement adjustment both in 2017 and in future performance years.


MIPS: Lawyers, Litigation, and Malpractice

By Jim Tate – Last week I documented yet another reason that the achievement of a high MIPS score should be Priority One for Eligible Clinicians. 2017 has been defined as the “Transition Year” for MACRA/MIPS and minimum standards have been put in place to allow minimal effort to avoid 2019 Part B adjustments.


MIPS: Loan Acquisition and Maintenance

By Jim Tate – We have reflected in earlier posts the critical importance of achieving a high MIPS score. Reimbursment, practice value, and professional reputation are all directly impacted by a MIPS score. Here is yet another collateral impact of a MIPS score: the ability to obtain and maintain a loan.





Reflections on the US HIT Policy Trajectory

By John Halamka MD – I’m in China this week, meeting with government, academia, and industry leaders in Guangzhou, Shenzhen, Beijing, Shanghai, and Suzhou. The twelve hour time difference means that I can work a day in China, followed by a day in Boston. For the next 7 days, I’ll truly be living on both sides of the planet.